Viewing Study NCT06140966

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:43 PM
Ignite Modification Date: 2026-06-25 @ 9:07 PM
Study NCT ID: NCT06140966
Status: RECRUITING
Last Update Posted: 2025-04-16
First Post: 2023-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Primary Plasma Cell Leukemia View
None Extramedullary Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Daratumumab View
None Carfilzomib View
None Multiple Myeloma View
None Ultra High-risk View
None Primary Plasma Cell Leukemia View
None Extramedullary Multiple Myeloma View
None Autologous stem cell transplant View
None Double hit View